Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kisspeptin-54 for Oocyte Maturation in IVF
NCT01667406Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jun 2012
- Primary completion
- Oct 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of kisspeptin in infertility (10 arms), sponsored by Imperial College London. Primary endpoint: Percentage of Oocyte Maturation. Started Jun 2012; status: completed.
02
Drugs
kisspeptin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01667406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667406.